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People living with HIV (PLWH) are often culturally and linguistically diverse populations; 
these differences are associated with differing barriers to antiretroviral therapy (ART) 
adherence. Cultural competence measures the extent to which trial design recognises this 
diversity. This systematic review aimed to determine whether adherence trial participants 
represent the diversity of PLWH.  
Randomised Controlled Trials in Organisation for Economic Co-operation and Development 
countries to improve ART adherence were eligible. We searched MEDLINE, EMBASE, and 
Cochrane Database of Systematic Reviews. For all included trials, we searched for their 
development, testing and evaluation studies. We compared trial participant characteristics 
with nationally reported PLWH data. We appraised trial cultural competence against ten 
criteria; scoring each criterion as 0, 1 or 2 indicating cultural blindness, pre-competence or 
competence respectively.  
For 80 included trials, a further 13 studies presenting development/testing/evaluation data for 
the included trials were identified. Only one of the 80 included studies reported trial 
participants representative of the country’s population of PLWH. The median (IQ) cultural 
competence score was 2.5 (1.0, 4.0) out of 20. HIV adherence trial participants are not 
reflective of the population with HIV, which may be due to limited adoption of culturally 
competent research methods.  
 








Sub-optimal adherence to Antiretroviral treatment (ART) in people living with HIV (PLWH) 
has led to numerous adherence interventions (Kanters et al., 2017). Implementation of these 
interventions into routine care has been limited (Simoni et al., 2017) and may reflect poor 
acceptability and feasibility in the real world environment (de Bruin et al., 2010).   
PLWH are often culturally and linguistically diverse populations (Hernando et al., 2015) with 
differing barriers to ART adherence (Croome, et al. 2017; Shubber et al., 2016). Socio-cultural 
factors such as low levels of social support, poor health/medical knowledge, culturally 
mediated negative beliefs about ART and stigmatisation are all associated with sub-optimal 
ART adherence (Ammassari et al., 2002). In most Organisation for Economic Co-operation 
and Development (OECD) countries, HIV/AIDS disproportionately affect migrants. Whilst 
accounting for less than 16% of the European Union population, 40% of PLWH in the 
European Union are migrants (Hernando et al., 2015).  Similar disproportionate representation 
is observed in the USA (Prosser, Tang, & Hall, 2012). ART adherence interventions should 
therefore recognise this cultural diversity during the research development, evaluation and 
implementation phases.  
Trial reporting guidelines specifying the need for baseline demographics do not adequately 
reflect the complexities of cultural identity and how it is socially constructed in language 
(Schulz et al., 2010). However, these demographics are the best available data for assessing 
cultural diversity.  
Cultural competence is as an “ongoing capacity of healthcare systems, organizations, and 
professionals to provide for diverse patient populations high-quality care that is safe, patient 
and family centred, evidence based, and equitable” (National Quality Forum 2008). Gibbs et 
al. (2007) report a cultural competence research framework comprising nine criteria spanning 
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the processes of study design, recruitment, analysis and dissemination all being in partnership 
with the target population. This framework has been applied to evaluate observational studies 
(Riggs et al., 2014) but it is yet to be applied to randomised controlled trials (RCT). The need 
for brevity in RCT trial reporting may prohibit full characterisation of intervention 
development and subsequent evaluation. However, facilities for publishing protocols, 
feasibility, pilot and process evaluation studies allows ample opportunity for researchers to 
report additional data. Trials, as a component of CONSORT reporting, routinely provide the 
demographic characteristics of participants (Schulz et al. 2010) thus providing the minimum 
necessary data to evaluate the extent to which participants reflect the population with HIV.   
This study aimed to characterise the extent to which ART adherence intervention trials 
conducted in OECD countries are designed and implemented in recognition of the diversity of 
the population for which the intervention is intended. 
 
Materials and Methods 
Phase 1. Identifying relevant RCTs 
The study followed the Preferred Reporting Items for Systematic reviews and Meta-Analysis 
(Moher et al., 2009) and was registered in PROSPERO (CRD42017077501). RCTs reported in 
English of any intervention to improve adherence to ART by adults were eligible. The review 
included all health care settings in OECD countries. We limited to OECD countries through 
manual searches of identified RCTs. We excluded studies using real-time monitoring for 
measuring adherence as they are subject to reactivity bias and thus less likely to be used to 
inform policy and practice. 
RCTs were identified through searches of MEDLINE, EMBASE, and Cochrane Database of 
Systematic Reviews. Supplementary file 1 provides the search strategy adapted for each 
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database to accommodate different syntax rules. Two researchers (XW and NW) independently 
screened all titles and abstracts for relevance using an abstract screening tool (supplementary 
file 2). All retrieved articles were assessed for eligibility. Conflicts were resolved by discussion 
between the two reviewers and any disagreement by adjudication of a third independent 
reviewer (DB).  
Phase 2. Identifying development, testing and evaluation studies related to included RCTs 
Articles were eligible if they reported development, feasibility/piloting, evaluation or 
implementation of one or more intervention components from RCTs included at phase 1. We 
used the UK Medical Research Council definition of these research phases to determine 
eligibility (Craig et al., 2008). 
BA undertook individualised searches for every author of RCTs included from phase 1. This 
identified any related publications on Pubmed, ResearchGate and Google Scholar. BA and DB 
independently reviewed all retrieved articles for eligibility. 
Data extraction 
An Excel data extraction sheet was developed for capturing participant socio-demographic 
characteristics and trial conduct data. Data were extracted verbatim thus terminologies for 
socio-demographic characteristics may have been specific to the country in which the study 
was conducted. Data were independently extracted by (XW, NW and BA); any discrepancies 
resolved by a third reviewer (DB).  
 
Quality assessment 
Definitions for each of the nine Gibbs et al. criteria for culturally competent research were 
adapted by the research team to better reflect the language of RCTs. The criterion 
‘analysis/evaluation’ was split into two separate criteria for RCT conduct (Figure 1). 
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[Figure 1 about here] 
 
Data analysis  
For each included study, if the reporting of socio-demographic characteristics enabled them to 
be attributed to individual countries, then these were compared with the sociodemographic 
characteristics of the country’s population with HIV, providing that these data were publicly 
available. This enabled us to establish the extent to which the trial population represented the 
diversity of the PLWH population. 
For each of the ten criteria, XW and NW independently rated included studies on a scale of 0 
to 2 for each of the ten criteria (Figure 1); any disagreements were referred to DB for 
arbitration. Lack of reporting prohibits the reader from evaluating the likely applicability of the 
research findings for any given population hence this was categorised as 0.   
 
Results  
Figure 2 provides the flow of studies; of the 80 studies retained in this systematic review, 66 
(83%) were conducted in the USA, three in France (4%), two in Spain (2.5%), and one each in 
Canada (1%), Holland (1%) and Switzerland (1%). The remaining six (8%) were conducted in 
multiple OECD countries. Adherence interventions were wide ranging and included reminder 
devices, electronic communication such as short message service and face-to-face 
consultations. From the 13 relevant articles identified in phase 2 searches, five focussed on 
post-trial evaluation, however only one of these studies contributed extra data for assessing 
cultural competence (Garland et al., 2007). All eight of the trial developmental studies from 
the phase 2 searches contributed extra information to assess cultural competence. They 
provided details of early engagement and/or intervention refinement resulting from engaging 
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with the target population (Altice et al., 2004; Dilorio et al., 2003; Golin et al., 2016; Ingersoll 
et al., 2014; Macalino et al., 2004; Moore et al., 2013; van Servellen et al., 2003; Wohl et al., 
2004). 
 




Table 1 provides the extent to which trial participants represent the country’s population 
prescribed ART. Only one study was representative based on the reported characteristics, 
however, this study did not report sexual orientation and/or mode of HIV acquisition (Enriquez 
et al., 2015). Supplementary file 3 provides details of trial participant characteristics. Only 35 
(43%) studies reported sexual orientation and for eight of these studies, men who have sex with 
men contributed over 70% of participants (Antoni et al., 2006; de Bruin et al., 2010; Johnson 
et al., 2011; Kurth et al., 2014; Ramirez-Garcia & Côté, 2012; Roth et al., 2012; Safren et al., 
2001; Wagner et al., 2013). 
 
[Table 1 about here] 
 
Cultural competence assessment  
No studies achieved the maximum cultural competence score of twenty. The median 
(interquartile) cultural competence score was 2.5 (1.0, 4.0). Table 1 provides the summary 
scores for each study’s cultural competence assessment. The highest score was 12 and this was 
the only study reporting participants representative of the country’s HIV population. Figure 3 
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illustrates the limited number of studies adopting culturally competent methods across the ten 
criteria. Studies generally performed better for the criteria of ‘identifying the target population’ 
and ‘developing the intervention’ whilst reported involvement of the target population in 
disseminating trial findings was absent. 
 
[Figure 3 about here] 
 
Forming partnerships and defining research questions  
Limited patient involvement was reported during the stage of conceiving the research ideas. 
Figure 2 indicates slightly better performance in forming partnerships relative to defining 
research questions. Three studies were rated as culturally competent as they involved 
participants during the design stage to consider their preferences (Ingersoll et al., 2015; 
Ingersoll et al., 2011; Safren et al., 2012). One trial was rated as culturally pre-competent 
because even though they did not reach out to the target community, the research team 
comprised PLWH and they were involved in the design, implementation and evaluation of the 
trial (Enriquez et al., 2015).   
 
Identifying the target population 
A medical setting such as HIV clinics were the recruitment source for 54 (68%) trials. These 
trials were characterised as pre-competent as the involvement of health care providers in the 
recruitment process may introduce bias. Recruitment from community settings including 
community outreach (Antoni et al., 2006) and primary care providers (Collier et al., 2005; 
Ingersoll et al., 2011; Kalichman et al., 2011; Kurth et al., 2014; Parsons et al., 2007; Pellowski 
et al., 2016; Remien et al., 2005; Safren et al., 2016; Safren et al., 2003) was adopted in ten 
studies whilst nine studies adopted multiple strategies including various combinations of HIV 
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clinics, primary care providers, and local advertisements (Dale et al., 2016; Duncan et al., 2012; 
Enriquez et al., 2015; Gwadz et al., 2015; Huhn et al., 2017; Johnson et al., 2011; Johnson et 
al., 2007; Safren et al., 2001; Williams et al., 2006).  
 
Appointing staff 
Representation of the target population in the research team was limited to seven (9%) studies. 
For five studies, PLWH were directly involved in intervention delivery (Enriquez et al., 2015; 
Gwadz et al., 2015; Simoni et al., 2007; Simoni et al., 2009; Williams et al., 2006). For the 
remaining two studies, research teams included community representatives and relevant 
bilingual workers guiding the research conduct (Floris-Moore et al., 2016; van Servellen et al., 
2005).   
 
Recruitment of sample 
Most of the studies included recruitment restrictions such as ‘must provide written informed 
consent’. Two studies translated consent materials to make them accessible to the target 
populations of both English and Spanish speakers (Enriquez et al., 2015; Wohl et al., 2006). 
One study explicitly commented that their driver for excluding potential participants who could 
not read and speak English was the challenge of creating research and intervention materials 
for diverse populations (de Bruin et al., 2010).  
 
Data collection 
The data collection processes for only 22 (27%) studies catered to a culturally and linguistically 
diverse population. These included translating project materials (Collier et al., 2005; Samet et 
al., 2005); engaging bilingual community workers for data collection (Garland et al., 2007; van 
Servellen et al., 2005; Williams et al., 2006; Wohl et al., 2006); flexible session times (Kurth 
et al., 2014; Reynolds et al., 2008; Robbins et al., 2013); tailoring intervention activities based 
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on individual patient needs (Antoni et al., 2006; Gwadz et al., 2015); flexible locations 
(Garland et al., 2007; Johnson et al., 2011; Johnson et al., 2007; Macalino et al., 2007; Roth et 
al., 2012); providing male-female facilitator pairs (Kalichman et al., 2011); and flexible 
intervention delivery methods (Murphy et al., 2007; Pellowski et al., 2016). Others provided 
childcare (Holstad et al., 2011); matched project peers to participants on the basis of ethnicity, 
sex, and sexual orientation (Simoni et al., 2007; Simoni et al., 2009); and included patient 
participation in the intervention (Moore et al., 2015).   
 
Development of intervention 
Almost half of the trials (53%) customised the intervention for the target population such as 
varying intervention content (Johnson et al., 2011; Johnson et al., 2007; Kalichman et al., 2011; 
Kurth et al., 2014; Mannheimer et al., 2006; Parsons et al., 2007; Wagner et al., 2006; Wagner 
et al., 2013; Weber et al., 2004), location (Garland et al., 2007; Macalino et al., 2007; Roth et 
al., 2012) and frequency (de Bruin et al., 2010; Dilorio et al., 2008; Tuldra et al., 2000) 
according to participant preference or feedback. Enriquez et al. (2015) partnered PLWH with 
the researchers to translate a nurse-led intervention to a peer-led format (Enriquez et al., 2015). 
Other studies tailored the intervention for participants with lower health literacy skills 
(Pellowski et al., 2016; Rawlings et al., 2003). Several studies included consultation with 
patients (Robbins et al., 2013; Safren et al., 2016; Simoni et al., 2007; Simoni et al., 2009) and 
evaluation mechanisms to inform the next stage of the intervention (Holzemer et al., 2006). 
Preliminary needs assessment of participants (Wohl et al., 2017) and co-designing intervention 
materials were reported Moore et al (2015). Other cultural considerations were translation of 
written materials (Collier et al., 2005) and bilingual community workers (van Servellen et al., 
2005).  
 
Analysis and Evaluation 
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Two studies reported involving the target population in data analysis (Enriquez et al., 2015) 
(Macalino et al., 2007). Eight studies invited feedback from participants, primarily using post-
trial intervention satisfaction surveys (Arribas et al., 2017; Rathbun et al., 2005; de Bruin et 
al., 2010; Garland et al., 2007; Himelhoch et al., 2017; Ingersoll et al., 2015; Ingersoll et al., 
2011; Kurth et al., 2014). Some conducted post-trial evaluations with staff involved in 
intervention delivery (de Bruin et al., 2010; Himelhoch et al., 2017).  
 
Dissemination 
No studies reported disseminating findings back to the participants or target population.   
 
Discussion 
This review confirms that most HIV adherence trial participant populations are not 
representative of the target population. Notable differences are lower representation of ethnic 
minorities, females and heterosexual males. As differing sociodemographic factors are 
associated with differing barriers to ART adherence (Shubber et al., 2016), trial findings should 
be interpreted with caution when considering implementation into the real-world environment. 
The review also demonstrates that it is feasible to evaluate the cultural competence of RCTs 
but trial reporting quality prohibits comprehensive evaluation. 
Cultural competence criteria align better with feasibility and process evaluation rather than 
RCT reporting standards (Schulz et al., 2010). However, few studies of these types were 
identified in this review. Due to inadequate reporting, we are therefore unable to conclusively 
state that trials are not adopting culturally competent methods. The limited diversity observed 
in trial participants, however, supports the conclusion that trials are failing to adopt culturally 
competent methods. Poor reporting also prohibits commissioners evaluating the extent to 
which trial findings are generalisable to their population. This may have contributed to the 
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limited adoption of novel adherence interventions into routine care (de Bruin et al., 2010; 
Simoni et al., 2017). 
Our synthesis of studies spanning 17 years indicates no observable trend in either improvement 
or decline in reporting of culturally competent research methods. A range of OECD countries 
are represented but the majority of studies were conducted in the USA. The general 
disproportionately high representation of males in the USA trials with lower cultural 
competence scores is of concern particularly as the rate of females diagnosed with HIV has 
shown a smaller decline than males (Centers for Disease Control and Prevention, 2017). 
Whilst characteristics relating to ethnicity, gender, sexuality and class specified in CONSORT 
criteria (Schulz et al., 2010) do not adequately reflect the complexities of cultural identity, there 
is limited reporting of even these characteristics. The message regarding fulfilling CONSORT 
standards may need strengthening. This may be achieved by specifying the minimum 
characteristics reported for behavioural intervention studies.  
The relatively good performance of most studies for identifying the target population and data 
sources was due to using the clinical environment for recruitment and data collection. As the 
target population is people prescribed ART and HIV clinic attendance is a pre-requisite for 
receiving ongoing ART treatment, this provides a relatively comprehensive sampling frame for 
recruitment. In contrast, few studies achieved trial participants representative of the country’s 
population diagnosed with HIV in terms of ethnicity and sex; poverty of reporting precludes 
drawing conclusions regarding representation in terms of sexual orientation, mode of HIV 
acquisition and migrant status. As the procedure for identifying the target population was 
largely appropriate, the poor representation of the population with HIV may be a facet of 




Few studies engaged the target population to develop the research questions and intervention. 
This can result in misaligned questions and sub-optimal intervention design (Gibbs, 2008) due 
to insufficient researcher understanding of the problem (Brett et al., 2014). 
Social, cultural and personal differences influence the balance of power and hierarchy between 
the researcher and those being researched, especially in terms of intersectionality (DeVault and 
Gross, 2012). Consequently, hierarchical relationship between patients and healthcare team 
members who were mainly used for recruitment purposes introduces potential for consent bias 
(Nnaji et al., 2018). This may explain the observed poor representation of females and migrants 
(Hughson et al., 2016). Bias in recruitment processes may have been further compounded by 
the limited evidence of tailored consent processes such as language translations (Hunt & de 
Voogd, 2007). Incongruously, several studies reported translation of material and multi-lingual 
research staff for data collection processes. This discordance may reflect inadequate reporting 
rather than poor trial methods. Adherence to international guidelines for reporting patient and 
public involvement (Staniszewska et al., 2017) would enable confirmation of the extent to 
which the target audience were involved in the design, conduct and reporting of the research, 
however no studies acknowledged this guidance. Whilst the reasonable level of target audience 
involvement in designing and tailoring interventions is encouraging, approaches were far 
removed from the growing co-design literature that positions end users as integral to the 
innovation process (Bate & Robert, 2006).   
A dissemination approach that garners support from the target patient/public population 
provides a driving force for implementation (Shippee et al., 2015). The almost non-existent 
presence of patients prescribed ART or their representatives in the analysis, evaluation and 
dissemination processes may therefore provide some explanation for the limited 
implementation of interventions (de Bruin et al., 2010; Simoni et al., 2017). 
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Assessing the cultural competence of HIV adherence trials or any RCT is innovative. 
Implications for future research are that culturally competent research methods should be 
adopted. This required change may be supported by refining trial reporting standards and 
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Figure 1: Quality assessment criteria and their rating 
 
Assessment criteria 
The following ten criteria for culturally competent research were used to assess the quality of included studies: 
 
1. Forming partnerships  
Did the researchers work through gatekeepers to establish relationships with the target population?  
2. Defining research questions  
Was the intervention identified and initiated in consultation with the target population?  
3. Identifying the target population and data sources 
Did the research team frame data collection to facilitate the target population?  
4. Appointing staff  
Does the research team include representation of the target population?  
5. Recruitment sample  
Was the consent process tailored for the target population including awareness of within cultural variations?  
6. Data collection  
Was the data collection process tailored for the target population? 
7. Development of intervention  
Were the target population involved in the development/customisation of the intervention?  
8. Analysis 
Were research team members representing the target population involved in the analysis and interpretation of data? 
9. Evaluation 
Was there feedback from participants to confirm interpretation of the results? 
10. Reporting/Disseminating findings  
Did dissemination allow the target population to discuss trial findings and generate solutions? 
 
Rating 
These criteria were rated on a scale of 0 to 2 as follows: 
 
• Awarded 0 if – Culturally blind, which describes methodological approaches underpinned by the belief that 
neither colour nor culture influence behaviour and that all people are the same 
 
• Awarded 1 if – Culturally pre-competent, which describes approaches recognising that the dominant race or 
culture of a country is not universally applicable but fails to fully attend to cultural differences 
 
 
• Awarded 2 if - Cultural competent, which describes approaches recognising the cultural diversity of the 
intended population 
 
Criteria were adapted from Gibbs, et al. (2007) 
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Country Race/Ethnicity Sex 
Sexual Orientation and/or 
mode of HIV acquisition 
Cultural 
competence score* 
Smith, S. R. 2003 USA Representative Not representative NA 1 
Enriquez, M. 2015 USA Representative Representative NA 12 
Andrade, A. S. A. 2005 USA Not representative Not representative NA 1 
Macalino, G. E. 2007 USA Not representative Representative NA 7 
Goggin, K. 2013 USA Representative Representative Not representative 3 
Simoni, J. M. 2007 USA Not representative Not representative NA 5 
Samet, J. H. 2005 USA Representative Not representative Not representative 4 
Collier, A. C. 2005 USA, Puerto Rico, Italy Not representative Not representative NA 5 
Wohl, A. R. 2006 USA Not representative Representative Not representative 5 
Levin, T. P. 2006 USA Not representative Not representative NA 1 
Huhn, G. D. 2017 USA Not representative Representative NA 2 
Ramirez-Garcia, P. 2012 Canada Not representative Not representative Not representative 3 
Floris-Moore, M. A. 2016 USA Representative Not representative NA 0 
Dale, S. K. 2016 USA Not representative Not representative Not representative 3 
Gwadz, M 2015 USA Not representative Not representative Not representative 7 
Doerfler, R. E.  2016 USA Not representative Not representative NA 2 
Roth, A. M. 2012 USA Not representative Not representative Representative 4 
Robbins, G. K. 2016 USA Not representative Not representative NA 0 
Safren, S. A. 2012 USA Not representative Not representative Not representative 6 
Safren, S. A. 2016 USA Not representative Not representative Not representative 3 
Wagner, G. J. 2006 USA Not representative Representative Not representative 2 
Kurth, A. E. 2014 USA Not representative Not representative Not representative 7 
Remien, R. H. 2005 USA Not representative Not representative Not representative 2 
Lucas, G. M. 2013 USA Not representative Not representative NA 1 
Berg, K. M. 2011 USA Not representative Not representative NA 1 
Perez-Molina, J. A. 2015 Spain 79% Native Population Not representative Not representative 1 
Calderón, M. M. 2016 USA Not representative Not representative NA 0 
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White, B. L. 2015 USA Not representative Not representative Not representative 1 
Johnson, M. O. 2007 USA Not representative Representative Not representative 6 
Van Servellen, G. 2005 USA Not representative Not representative Not representative 7 
Slama, L. 2016 France 63% European Representative Not representative 0 
Pradier, C. 2003 France NA Not representative NA 2 
Javanbakht, M. 2006 USA Not representative Not representative NA 3 
de Bruin, M. 2010 Holland 100% White Not representative 
Int: Homosexual (78%) 
Control: Homosexual (67%) 
5 
Holstad, M. 2011 USA Not representative Not representative Not representative 4 
Williams, A. B. 2006 USA Not representative Not representative NA 8 
Miro, J. M. 2015 Spain 65% Spain/W Europe Representative Not representative 1 
Goujard, C. 2003 France NA Representative NA 1 
Rathbun, R. C. 2005 USA Not representative Not representative Not representative 3 
Rawlings, M. K. 2003 USA Not representative Not representative Not representative 2 
Rosen, M. I. 2007 USA Not representative Not representative NA 2 
Moore, D. J. 2015 USA Not representative Not representative NA 6 
Kalichman, S. C. 2011 USA Not representative Not representative Not representative 5 
Duncan, L. G. 2012 USA Not representative Not representative NA 2 
Gross, R. 2009 USA, Puerto Rico Not representative Representative NA 1 
Pellowski, J. A. 2016 USA Not representative Not representative NA 5 
Brunetta, J. 2015 
Canada, Spain, Italy, 
France, USA, UK 
Not representative Not representative NA 1 
Wilkins, E. L. 2016 Canada, Germany, UK Not representative Not representative NA 0 
Simoni, J. M. 2009 USA Not representative Representative NA 5 
Wagner, G. J. 2013 USA Not representative Not representative Not representative 2 
Himelhoch, S. 2017 USA Not representative Not representative NA 3 
Konkle-Parker, D. J. 2012 USA Not representative Not representative NA 1 
Tuldrà, A.  2000 Spain, Holland NA Not representative Not representative 2 




information not reported in the study/relevant data reported in the study presented where national HIV statistics not found. National HIV statistics were 
Wohl, D. A. 2017 USA Not representative Representative NA 5 
Murphy, D. A. 2007 USA Representative Not representative NA 3 
Huhn, G. D. 2015 USA Not representative Not representative NA 0 
Arribas, J. R. 2017 USA, Europe Not representative Not representative NA 3 
Robbins, G. K. 2013 USA, Italy Not representative Not representative NA 3 
Altice, F. L. 2007 USA Not representative Not representative NA 1 
Mannheimer, S. B. 2006 USA Not representative Representative NA 3 
Reynolds, N. R. 2008 USA Not representative Not representative NA 5 
Holzemer, W. L. 2006 USA Not representative Not representative NA 3 
Garland, W. H. 2007 USA Not representative Representative Not representative 8 
Wohl, D. A. 2016 USA Not representative Representative NA 1 
Pence, B. W. 2015 USA Not representative Not representative Not representative 2 
Schafer, J. J. 2015 USA Not representative Representative NA 1 
Safren, S. A. 2001 USA Not representative Not representative Not representative 2 
Safren, S. A. 2003 USA Not representative Representative Not representative 2 
Dilorio, C. 2008 USA Not representative Not representative Not representative 3 
Alsan, M. 2017 USA NA NA NA 1 
Ingersoll, K. S. 2011 USA Not representative Not representative Not representative 8 
Weber, R. 2004 Switzerland NA 
Int: 25% female 
Cont: 7.1% female 
Representative 2 
Maru, D. SR. 2009 USA Not representative Not representative NA 3 
Johnson, M. O. 2011 USA Not representative Not representative Not representative 5 
Parsons, J. T. 2007 USA Not representative Representative Not representative 4 
Gross, R. 2013 USA Not representative Not representative NA 3 
Hersch, R. K. 2013 USA Not representative Representative NA 2 
Ingersoll, K. S. 2015 USA Not representative Not representative NA 6 
Magidson, J. F. 2015 USA Not representative Representative NA 1 
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obtained from CDC HIV surveillance report and HIV/AIDS surveillance in Europe (WHO) report. *Scored as 0 (culturally blind), 1 (culturally pre-competent) 
or 2 (culturally competent) across 10 criteria; total score can range from 0 (culturally blind) to 20 (culturally competent).  
 
